These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35866628)

  • 1. Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status.
    Momboisse F; Nardi G; Colin P; Hery M; Cordeiro N; Blachier S; Schwartz O; Arenzana-Seisdedos F; Sauvonnet N; Olivo-Marin JC; Lagane B; Lagache T; Brelot A
    Elife; 2022 Jul; 11():. PubMed ID: 35866628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.
    Hüttenrauch F; Pollok-Kopp B; Oppermann M
    J Biol Chem; 2005 Nov; 280(45):37503-15. PubMed ID: 16144840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 adopts three homodimeric conformations that control cell surface delivery.
    Jin J; Momboisse F; Boncompain G; Koensgen F; Zhou Z; Cordeiro N; Arenzana-Seisdedos F; Perez F; Lagane B; Kellenberger E; Brelot A
    Sci Signal; 2018 May; 11(529):. PubMed ID: 29739880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 structural plasticity shapes HIV-1 phenotypic properties.
    Colin P; Zhou Z; Staropoli I; Garcia-Perez J; Gasser R; Armani-Tourret M; Benureau Y; Gonzalez N; Jin J; Connell BJ; Raymond S; Delobel P; Izopet J; Lortat-Jacob H; Alcami J; Arenzana-Seisdedos F; Brelot A; Lagane B
    PLoS Pathog; 2018 Dec; 14(12):e1007432. PubMed ID: 30521629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor.
    Jacquemard C; Koensgen F; Colin P; Lagane B; Kellenberger E
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of chemically-induced β-arrestin binding to chemokine receptors CXCR4 and CCR5 in the absence of ligand stimulation.
    Liebick M; Henze S; Vogt V; Oppermann M
    Cell Signal; 2017 Oct; 38():201-211. PubMed ID: 28733085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active CCR5 chemokine receptors differ in mediating HIV envelope-dependent fusion.
    de Voux A; Chan MC; Folefoc AT; Madziva MT; Flanagan CA
    PLoS One; 2013; 8(1):e54532. PubMed ID: 23355876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors.
    Isik N; Hereld D; Jin T
    PLoS One; 2008; 3(10):e3424. PubMed ID: 18923649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines.
    Colin P; Bénureau Y; Staropoli I; Wang Y; Gonzalez N; Alcami J; Hartley O; Brelot A; Arenzana-Seisdedos F; Lagane B
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9475-80. PubMed ID: 23696662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.
    Escola JM; Kuenzi G; Gaertner H; Foti M; Hartley O
    J Biol Chem; 2010 Dec; 285(53):41772-80. PubMed ID: 21041313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.
    Hammad MM; Kuang YQ; Yan R; Allen H; Dupré DJ
    J Biol Chem; 2010 Nov; 285(45):34653-64. PubMed ID: 20801883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the trans-dominant negative effect of truncated forms of the CCR5 chemokine receptor.
    Chelli M; Alizon M
    J Biol Chem; 2001 Dec; 276(50):46975-82. PubMed ID: 11600494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the mechanisms whereby low molecular weight CCR5 ligands inhibit HIV-1 infection.
    Garcia-Perez J; Rueda P; Staropoli I; Kellenberger E; Alcami J; Arenzana-Seisdedos F; Lagane B
    J Biol Chem; 2011 Feb; 286(7):4978-90. PubMed ID: 21118814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of HIV-1 receptor function through cooperation between different forms of the CCR5 chemokine receptor.
    Chelli M; Alizon M
    J Biol Chem; 2002 Oct; 277(42):39388-96. PubMed ID: 12154092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
    Jin J; Colin P; Staropoli I; Lima-Fernandes E; Ferret C; Demir A; Rogée S; Hartley O; Randriamampita C; Scott MG; Marullo S; Sauvonnet N; Arenzana-Seisdedos F; Lagane B; Brelot A
    J Biol Chem; 2014 Jul; 289(27):19042-52. PubMed ID: 24855645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.
    Arnatt CK; Falls BA; Yuan Y; Raborg TJ; Masvekar RR; El-Hage N; Selley DE; Nicola AV; Knapp PE; Hauser KF; Zhang Y
    Bioorg Med Chem; 2016 Nov; 24(22):5969-5987. PubMed ID: 27720326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.
    Zheng Y; Han GW; Abagyan R; Wu B; Stevens RC; Cherezov V; Kufareva I; Handel TM
    Immunity; 2017 Jun; 46(6):1005-1017.e5. PubMed ID: 28636951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol impacts chemokine CCR5 receptor ligand-binding activity.
    Calmet P; Cullin C; Cortès S; Vang M; Caudy N; Baccouch R; Dessolin J; Maamar NT; Lecomte S; Tillier B; Alves ID
    FEBS J; 2020 Jun; 287(11):2367-2385. PubMed ID: 31738467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
    Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
    Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerization-Enhanced Receptor-Ligand Binding Revealed by Dual-Color Simultaneous Tracking on Living Cell Membranes.
    Li J; Ding Y; Liu H; He H; Yu D; Wang X; Wang X; Yu X; Ge B; Huang F
    J Phys Chem Lett; 2021 Sep; 12(34):8164-8169. PubMed ID: 34410720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.